Atomera Provides Third Quarter 2026 Results

Quarterly operating expenses fell from the second quarter but remained above their year-earlier level.

Rhea-AI Summary

Atomera (NASDAQ: ATOM) reported a third-quarter 2026 net loss of $6.006 million as revenue fell to zero. The loss widened from $5.573 million a year earlier but narrowed from $6.336 million in the second quarter. Basic and diluted loss per share was $0.15, versus $0.17 in both comparison quarters. Revenue compared with $11,000 a year earlier and $158,000 in the second quarter.

Cash, cash equivalents and short-term investments totaled $34.8 million at September 30, versus $19.2 million at December 31, 2025. Outstanding shares increased to 39.083 million from 32.354 million over that period. Nine-month revenue rose to $169,000 from $15,000, while net loss widened to $18.415 million from $15.749 million. Atomera increased its gate-all-around transistor customer engagements to three and signed a joint development agreement with IQE to bring radio-frequency gallium nitride technology to market.

10 points · 0 major

MixediHow this balance works

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

How the balance worksHow Sentiment works

1 major · 11 points

How the balance works

Positive

• Moderate pointCash, cash equivalents and short-term investments rose to $34.8 million from $19.2 million at year-end 2025.
• Minor pointGate-all-around customer engagements increased to three.
• Minor pointIQE joint development agreement signed to bring radio-frequency gallium nitride technology to market.
• Minor pointNine-month revenue increased to $169,000 from $15,000 a year earlier.
• Minor pointQuarterly loss per share narrowed to $0.15 from $0.17 both a year earlier and sequentially.

5 minor points

• Minor pointNine-month loss per share narrowed to $0.49 from $0.51 a year earlier.
• Minor pointQuarterly gross profit was zero versus a $117,000 year-earlier loss, but below $132,000 sequentially.
• Minor pointNine-month gross profit improved to $17,000 from a $175,000 loss a year earlier.
• Minor pointQuarterly interest income rose to $254,000 from $232,000 a year earlier and $172,000 sequentially.
• Minor pointInterest expense fell year over year to $7,000 quarterly and $12,000 over nine months.

Negative

• Major pointOutstanding shares increased to 39.083 million at September 30 from 32.354 million at year-end 2025, diluting holders.
• Moderate pointNine-month net loss widened to $18.415 million from $15.749 million a year earlier.
• Minor pointQuarterly revenue fell to zero from $11,000 a year earlier and $158,000 sequentially.
• Minor pointQuarterly net loss widened to $6.006 million from $5.573 million year over year, but narrowed sequentially from $6.336 million.
• Minor pointQuarterly adjusted EBITDA loss widened to $4.6 million from $4.4 million a year earlier.

6 minor points

• Minor pointResearch and development expense rose to $3.647 million quarterly and $10.391 million year-to-date, versus $3.304 million and $9.563 million.
• Minor pointGeneral and administrative expense rose year over year to $2.338 million quarterly and $7.838 million year-to-date.
• Minor pointSelling and marketing expense rose year over year to $343,000 quarterly and $1.199 million year-to-date.
• Minor pointOperating loss widened year over year to $6.328 million quarterly and $19.411 million over nine months.
• Minor pointTotal liabilities increased to $5.645 million at September 30 from $2.712 million at year-end 2025.
• Minor pointNine-month interest income declined to $623,000 from $736,000 a year earlier.

Argus 15 min delay 34 alerts

-6.95% vs previous close $3.08 last price 1.7x rel. volume Open Argus

Details

Market Reaction – ATOM

+5.4% Peak Tracked

-7.6% Trough Tracked

$2.92 – $3.35 Day Range

$120.19M Mkt Cap at Last Price

On Oct 29, the day this news came out, the latest delayed price for ATOM is 6.95% below the previous close. Argus tracked a peak move of +5.4% during the session. Argus tracked a trough of -7.6% from its starting point during tracking. Our momentum scanner has recorded 34 alerts for this stock so far that day. The latest delayed price is $3.08. Relative volume is above average at 1.7x the average.

Data tracked by StockTitan Argus (15 min delayed). Upgrade to Gold for real-time data.

Key Figures

Net loss: $6.0 million vs. $5.6 million Net loss per share: ($0.15) vs. ($0.17) Adjusted EBITDA loss: $4.6 million vs. $4.4 million +2 more

Net loss

$6.0 million vs. $5.6 million

Q3 2026 vs. Q3 2025

Net loss per share

($0.15) vs. ($0.17)

Basic and diluted, Q3 2026 vs. Q3 2025

Adjusted EBITDA loss

$4.6 million vs. $4.4 million

Q3 2026 vs. Q3 2025

Cash, cash equivalents and short-term investments

$34.8 million vs. $19.2 million

As of Sept. 30, 2026 vs. Dec. 31, 2025

Gate-all-around customer engagements

3 customers

Company highlight

Previous Earnings Reports

2 past events · Latest: Aug 04

Same Type 2 events

1. Aug 04

   Quarterly earnings

   24h Move

   -7.3%

   Reported a Q2 net loss and adjusted EBITDA loss.

2. Oct 28

   Quarterly earnings

   24h Move

   -2.5%

   Reported a Q3 net loss and adjusted EBITDA loss.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

adjusted ebitda, non-gaap financial measure, gate-all-around, dram

4 terms

adjusted ebitda financial

"Adjusted EBITDA (a non-GAAP financial measure) in the third quarter of 2026"

Adjusted EBITDA is a way companies measure how much money they make from their core operations, like running a business, by removing certain costs or income that aren’t part of regular business activities. It helps investors see how well a company is doing without distractions from unusual expenses or gains, making it easier to compare companies or track performance over time.

non-gaap financial measure financial

"Adjusted EBITDA (a non-GAAP financial measure) in the third quarter of 2026"

A non-GAAP financial measure is a way companies present their financial results that excludes certain expenses or income to show how they believe their core business is performing. It matters because it can give a clearer picture of how the company is really doing, but it can also be used to make results look better than they actually are.

gate-all-around technical

"Increased engagement count to three customers in gate-all-around"

Gate-all-around is a transistor design in which the control electrode wraps completely around the conducting path, like a tight sleeve around a wire, providing much stronger and more precise on/off control. For investors, this matters because the design enables smaller, faster and more energy-efficient chips, which can improve product performance, reduce power costs, and influence manufacturing complexity, capital spending and competitive position in the semiconductor supply chain.

dram technical

"enable next-generation DRAM transistors with MST"

A dram is a small, traditional unit used to measure either mass or liquid volume in manufacturing and pharmaceuticals — roughly 1.77 grams for a weight dram or about 3.7 milliliters for a fluid dram, similar to a small teaspoon or a couple of drops. Investors care because dram-based measurements affect drug dosing, packaging sizes, labeling compliance and raw-material usage, which in turn influence production costs, inventory counts and regulatory risk.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

LOS GATOS, Calif., Oct. 29, 2026 /PRNewswire/ -- ­­ Atomera Incorporated (NASDAQ: ATOM), a semiconductor materials and technology licensing company, today provided a corporate update and announced financial results for the third quarter ended Sept. 30, 2026.

Recent Company Highlights

• Increased engagement count to three customers in gate-all-around
• Signed a Joint Development Agreement with IQE to bring high-performance, cost-effective RF GaN to market
• Demonstrated simpler, lower cost approach to enable next-generation DRAM transistors with MST

Management Commentary

"This quarter we expanded our customer engagements in the advanced logic and memory segments, where AI continues to drive the need for higher transistor performance. Our ground-breaking nano-scale diffusion blocking work for gate-all-around transistors has generated interest not only with the GAA foundries, but also with designers of next generation memory solutions" said Scott Bibaud, president and CEO of Atomera. "While work in our traditional business is taking off, we also took an important step toward commercializing our GaN-on-silicon solutions by signing a joint development agreement with IQE, a leading supplier of compound semiconductor wafers."

Financial Results

The Company incurred a net loss of ($6.0) million, or ($0.15) per basic and diluted share in the third quarter of 2026, compared to a net loss of ($5.6) million, or ($0.17) per basic and diluted share, for the third quarter of 2025. Adjusted EBITDA (a non-GAAP financial measure) in the third quarter of 2026 was a loss of ($4.6) million compared to an adjusted EBITDA loss of ($4.4) million in the third quarter of 2025.

The Company had $34.8 million in cash, cash equivalents and short-term investments as of Sept. 30, 2026, compared to $19.2 million as of December 31, 2025. 

The total number of shares outstanding was 39.1 million as of September 30, 2026.

Third Quarter 2026 Results Webinar

Atomera will host a live video webinar today to discuss its financial results and recent progress.
Date: Thursday, Oct. 29, 2026
Time: 2:00 p.m. PT (5:00 p.m. ET)
Webcast: Accessible at https://ir.atomera.com 

Note about Non-GAAP Financial Measures
In addition to the unaudited results presented in accordance with generally accepted accounting principles, or GAAP, in this press release, Atomera presents adjusted EBITDA, which is a non-GAAP financial measure. Adjusted EBITDA is determined by taking net loss and eliminating the impacts of interest, depreciation, amortization and stock-based compensation. Our definition of adjusted EBITDA may not be comparable to the definitions of similarly-titled measures used by other companies. We believe that this non-GAAP financial measure, viewed in addition to and not in lieu of our reported GAAP results, provides useful information to investors by providing a more focused measure of operating results. This metric is used as part of the Company's internal reporting to evaluate its operations and the performance of senior management. A table reconciling this measure to the comparable GAAP measure is available in the accompanying financial tables below.

About Atomera Incorporated
Atomera Incorporated is a semiconductor materials and technology licensing company focused on deploying its proprietary, silicon-proven technology into the semiconductor industry. Atomera has developed Mears Silicon Technology™ (MST^®), which increases performance and power efficiency in semiconductor transistors. MST can be implemented using equipment already deployed in semiconductor manufacturing facilities and is complementary to other nano-scaling technologies already in the semiconductor industry roadmap. More information can be found at www.atomera.com. 

Safe Harbor
 This press release contains forward-looking statements concerning Atomera Incorporated, including statements regarding the prospects for the semiconductor industry generally and the ability of our MST technology to significantly improve semiconductor performance. Those forward-­looking statements involve known and unknown risks, uncertainties and other factors that could cause actual results to differ materially. Among those factors are: (1) the fact that, to date, we have only recognized minimal engineering services and licensing revenues thus subjecting us to all the risks inherent in an early-stage enterprise; (2) the risk that licensees or JDA customers do not advance to royalty-based manufacturing and distribution licenses; (3) our ability to add other licensees and/or JDA customers; (4) risks related to our ability to raise sufficient capital, as and when needed, to pursue the further development, licensing and commercialization of our MST technology; (5) our ability to protect our proprietary technology, trade secrets and know-­how and (6) those other risks disclosed in the section "Risk Factors" included in our Annual Report on Form 10-K filed with the SEC on February 24, 2026. We caution readers not to place undue reliance on any forward-looking statements. We do not undertake, and specifically disclaim any obligation, to update or revise such statements to reflect new circumstances or unanticipated events as they occur.

-- Financial Tables Follow –

Atomera Incorporated Condensed Balance Sheets (in thousands, except per share data)
		September 30,				December 31,
		2026				2025
		(Unaudited)
ASSETS
Current assets:
Cash and cash equivalents		$	23,268			$	19,210
Short-term investments			11,560				–
Interest receivable			152				54
Prepaid expenses and other current assets			456				338
Total current assets			35,436				19,602
Property and equipment, net			62				60
Security deposit			14				14
Operating lease right-of-use asset			2,731				884
Financing lease right-of-use-asset			196				533
Total assets		$	38,439			$	21,093
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable		$	868			$	608
Accrued expenses			522				168
Accrued payroll related expenses			1,326				650
Current operating lease liability			1,908				147
Current financing lease liability			198				420
Deferred Revenue			–				7
Total current liabilities			4,822				2,000
Long-term operating lease liability			823				712
Total liabilities			5,645				2,712
Commitments and contingencies			–				–
Stockholders' equity:			–				–
Preferred stock $0.001 par value, authorized 2,500 shares; none issued and      outstanding as of September 30, 2026 and December 31, 2025
Common stock: $0.001 par value, authorized 95,000 shares; 39,083 shares issued and       outstanding as of September 30, 2026; and 32,354 shares issued and outstanding as      of December 31, 2025			39				32
Additional paid in capital			292,874				260,043
Other comprehensive income (loss)			(10)				–
Accumulated deficit			(260,109)				(241,694)
Total stockholders' equity			32,794				18,381
Total liabilities and stockholders' equity		$	38,439			$	21,093

 

Atomera Incorporated Condensed Statements of Operations (Unaudited) (in thousands, except per share data)
	Three Months Ended																										Nine Months Ended
		September 30,							June 30,								September 30,										September 30,
		2026							2026								2025										2026							2025
Revenue		$	–						$		158						$	11									$	169							$		15
Cost of revenue			–								(26)							(128)										(152)									(190)
Gross margin			–								132							(117)										17									(175)
Operating expenses
Research and development			3,647								3,287							3,304										10,391									9,563
General and administrative			2,338								3,167							2,165										7,838									6,301
Selling and marketing			343								437							207										1,199									472
Total operating expenses			6,328								6,891							5,676										19,428									16,336
Loss from operations			(6,328)								(6,759)							(5,793)										(19,411)									(16,511)
Other income (expense)
Interest income			254								172							232										623									736
Accretion income			75								178							–										310									6
Interest expense			(7)								(1)							(12)										(12)									(51)
Other income, net			–								74							–										75									71
Total other income, net			322								423							220										996									762
Net loss		$	(6,006)						$		(6,336)						$	(5,573)									$	(18,415)							$		(15,749)
Net loss per common share, basic and diluted		$	(0.15)						$		(0.17)						$	(0.17)									$	(0.49)							$		(0.51)
Weighted average number of common shares      outstanding, basic and diluted			38,899								38,647							31,128										37,614									30,593

 

Atomera Incorporated Reconciliation to Non-GAAP EBITDA (Unaudited)
	Three Months Ended																								Nine Months Ended
		September 30,							June 30,									September 30,							September 30,
		2026							2026									2025							2026								2025
Net loss (GAAP)		$	(6,006)						$				(6,336)					$	(5,573)						$	(18,415)						$			(15,749)
Depreciation and amortization			10										6						11							25									35
Stock-based compensation			1,746										1,741						1,342							4,893									3,629
Interest income			(254)										(172)						(232)							(623)									(736)
Accretion income			(75)										(178)						–							(310)									(6)
Interest expense			7										1						12							12									51
Other income, net			–										(74)						–							(75)									(71)
Net loss non-GAAP EBITDA		$	(4,572)						$				(5,012)					$	(4,440)						$	(14,493)						$			(12,847)

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/atomera-provides-third-quarter-2026-results-302924164.html

SOURCE Atomera Incorporated

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What were Atomera's third-quarter 2026 revenue and earnings?

Atomera reported zero revenue and a $6.006 million net loss, or $0.15 per basic and diluted share. A year earlier, revenue was $11,000 and net loss was $5.573 million, or $0.17 per share.

How much cash and short-term investments did Atomera have at September 30, 2026?

Atomera held $34.8 million in cash, cash equivalents and short-term investments at September 30, 2026, compared with $19.2 million at December 31, 2025.

How did Atomera's operating expenses change in the third quarter of 2026?

Atomera's operating expenses totaled $6.328 million, down from $6.891 million in the second quarter but up from $5.676 million a year earlier. Research and development expense was $3.647 million, general and administrative expense was $2.338 million, and selling and marketing expense was $343,000.